Evidence map›Paper›PMID 26154306›Full record

ArticlePloS one2015

Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology.

Jillian Murray, Adam Cohen, Sibongile Walaza, Michelle Groome, Shabir Madhi, Ebrahim Variava, Kathleen Kahn, Halima Dawood, Stefano Tempia, Akhona Tshangela and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Impact of Human Immunodeficiency Virus on the Burden and Severity of Influenza Illness in Malawian Adults: A Prospective Cohort and Parallel Case-Control Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Jillian MurrayJohns Hopkins International Vaccine Access Center, Baltimore, Maryland, United States of America.
Adam CohenCenters for Disease Control and Prevention, Pretoria, South Africa; Centers for Disease Control and Prevention, Atlanta, United States of America.
Sibongile WalazaNational Institute of Communicable Diseases, Johannesburg, South Africa.
Michelle GroomeMedical Research Council: Respiratory and, Meningeal Pathogens Research Unit, Johannesburg, South Africa.
Shabir MadhiNational Institute of Communicable Diseases, Johannesburg, South Africa; Medical Research Council: Respiratory and, Meningeal Pathogens Research Unit, Johannesburg, South Africa; Schools of Public Health and Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Ebrahim VariavaKlerksdorp Tshepong Hospital, Klerksdorp, South Africa.
Kathleen KahnSchools of Public Health and Pathology, University of the Witwatersrand, Johannesburg, South Africa; University of KwaZulu-Natal, Durban, South Africa; Umeå University, Umeå, Sweden; INDEPTH Network, Accra, Ghana.
Halima DawoodUniversity of KwaZulu-Natal, Durban, South Africa; Pietermaritzburg Metropolitan Hospital Complex, Pietermaritzburg, South Africa.
Stefano TempiaCenters for Disease Control and Prevention, Pretoria, South Africa; National Institute of Communicable Diseases, Johannesburg, South Africa.
Akhona TshangelaNational Institute of Communicable Diseases, Johannesburg, South Africa.
Marietje VenterCenters for Disease Control and Prevention, Atlanta, United States of America; National Institute of Communicable Diseases, Johannesburg, South Africa; Zoonoses Research Unit, Department of Medical Virology, University of Pretoria, Pretoria, South Africa.
Daniel FeikinJohns Hopkins International Vaccine Access Center, Baltimore, Maryland, United States of America; Centers for Disease Control and Prevention, Atlanta, United States of America.
Cheryl CohenNational Institute of Communicable Diseases, Johannesburg, South Africa; Schools of Public Health and Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Respiratory and Meningeal Pathogens Research Unit · ZAJohns Hopkins University · USCenters for Disease Control and Prevention · USEdendale Hospital · ZAKalafong Hospital · ZAUniversity of KwaZulu-Natal · ZAUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Local disease burden data are necessary to set national influenza vaccination policy. In 2010 the population of South Africa was 50 million and the HIV prevalence was 11%. We used a previously developed methodology to determine severe influenza burden in South Africa. Hospitalized severe acute respiratory illness (SARI) incidence was calculated, stratified by HIV status, for four age groups using data from population-based surveillance in one site situated in Gauteng Province for 2009-2011. These rates were adjusted for each of the remaining 8 provinces based on their prevalence of risk factors for pneumonia and healthcare-seeking behavior. We estimated non-hospitalized influenza-associated SARI from healthcare utilization surveys at two sites and used the percent of SARI cases positive for influenza from sentinel surveillance to derive the influenza-associated SARI rate. We applied rates of hospitalized and non-hospitalized influenza-associated SARI to census data to calculate the national number of cases. The percent of SARI cases that tested positive for influenza ranged from 7-17% depending on age group, year, province and HIV status. In 2010, there were an estimated 21,555 total severe influenza cases in HIV-uninfected individuals and 13,876 in HIV-infected individuals. In 2011, there were an estimated 29,892 total severe influenza cases in HIV-uninfected individuals and 17,289 in HIV-infected individuals. The incidence of influenza-associated SARI was highest in children <5 years and was higher in HIV-infected than HIV-uninfected persons in all age groups. Influenza virus was associated with a substantial amount of severe disease, especially in young children and HIV-infected populations in South Africa.

Indexed as

Cost of IllnessSentinel SurveillanceHIV SeropositivityHospitalizationHumansIncidenceInfluenza, HumanModels, BiologicalSevere Acute Respiratory SyndromeSouth Africa

Identifiers

PMID26154306
PMCPMC4496064
OpenAlexW1798280854

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.